The Advisory Board was established in 2017 and consists of a diverse group of academic mentors. The purpose of the mentors on the Advisory Board is to provide:
- Guidance for the present and future direction of Vector, drawing on their experience in global health and academia;
- Real-life perspectives to inform Vector on its content and activities; and
- Scholarly endorsement to enhance the academic profile and reputation of Vector
Advisory Board Members
Dr Claudia Turner
Claudia is a consultant paediatrician and clinician scientist with the University of Oxford. Since 2015, she has been Chief Executive Officer of Angkor Hospital for Children. Claudia spent six years as a research paediatrician with the Shoklo Malaria Research Unit (SMRU) on the Thailand – Myanmar border where she worked in Maela Camp for displaced persons. She conducted research on infant and early childhood pneumonia and early onset neonatal sepsis. This work resulted in her PhD thesis describing in detail the epidemiology of these conditions in the refugee population and interventions which were successful in substantially reducing neonatal mortality. In 2012 Claudia moved to Cambodia to be the Director of Clinical Research at the Cambodia Oxford Medical Research Unit in Siem Reap, Cambodia, a close collaborative partner of the Angkor Hospital for Children.
Claudia’s current research interests include:
- Neonatal healthcare in resource poor settings
- Childhood pneumonia
- Healthcare implementation research
- Antibiotic stewardship
Dr David Hilmers
Dr. Hilmers is a Professor in the Departments of Internal Medicine and Pediatrics, the Center for Global Initiatives, and the Center for Space Medicine at the Baylor College of Medicine in Houston, Texas. In addition to teaching, his clinical pursuits have included international HIV, pediatrics special needs, adolescent medicine, emergency medicine, and inpatient internal medicine. His research interests have included infectious diseases such as malaria, HIV and Ebola, as well as refugee health, micronutrient malnutrition, and metabolic syndrome. He has done volunteer service and disaster relief work throughout the world. He served as a member and first chairman of the National Space Biomedical Research Institute’s User Panel. Prior to entering medical school at the age of 42, he was a Marine Corps colonel, aviator and electrical engineer and served as a NASA astronaut on four space shuttle missions.
A/Prof Nicodemus Tedla
Nicodemus Tedla is an Associate Professor at UNSW School of Medical Sciences: Leader of Innate Immune Regulation Research Group. He is a member of the American Association of Immunologists and Australasian Society of Experimental Pathology
His research interests include:
- Mechanisms of early innate immune regulation and the consequence of their dysregulation in development of autoimmune inflammatory diseases.
- Early innate immune responses to infections and understanding the nexus between innate immunity and non-neutralising antibody responses in HCV infections.
Dr Nick Walsh
Nick Walsh is medical doctor with qualifications through the Royal Australasian College of Physicians, and a clinical background in the screening, care and treatment of hepatitis, in particular B and C, and HIV in Australia and Cambodia. He also has substantial experience in a number of other clinical domains including addiction medicine, infectious diseases, emergency and internal medicine and has worked extensively in indigenous communities in northern Australia. He has a public health background with particular experience in HIV and viral hepatitis in the Asia Pacific and Australia, and has consulted since 2006 to the World Health Organization including from 2009 to WHO Headquarter’s HIV department, Global Hepatitis Programme and Mental Health and Substance Abuse. He has contributed to the development of global guidance on viral hepatitis B and C and opioid overdose. He holds a PhD in epidemiology from Monash University.
He lived and worked in public health and clinic medicine in Vietnam in 2002 and in Cambodia from 2008 – 2014. From 2014 he was the focal point for viral hepatitis, within the HIV, Hepatitis and STI unit in Communicable Diseases at the World Health Organization Regional Office for the Western Pacific in Manila, Philippines. In early 2017 he moved to The Pan American Health Organization/ WHO Regional Office for the Americas as Regional Advisor for the 35 countries across the Americas and Caribbean.